解剖鼻烟壶(远端桡动脉)与桡动脉入路使用FDA批准的血流导向装置治疗颅内动脉瘤
这项高容量双中心回顾性分析纳入2018年6月至2020年6月经桡动脉入路(远端桡动脉/解剖鼻烟壶及桡动脉)置入血流导向装置治疗颅内动脉瘤的74例患者(86个动脉瘤),经桡动脉入路成功率为95.9%(71/74),3例(4.1%)因血管迂曲、导管支撑不足或迷走右锁骨下动脉需转股动脉,未发生入路部位并发症,1例(3.7%)出现无症状桡动脉闭塞。作者结论认为血流导向装置可经桡动脉入路成功置入,技术成功率高、入路并发症低、转股动脉率低。
要点
- 经桡动脉(含远端桡动脉/解剖鼻烟壶)入路置入血流导向装置治疗颅内动脉瘤技术成功率为95.9%(71/74)。
- 3例(4.1%)需转股动脉:2例因血管迂曲、导管支撑不足,1例因迷走右锁骨下动脉无法到达目标血管。
- 未发生入路部位并发症,1例(3.7%)出现无症状桡动脉闭塞。
核心结论
- 血流导向装置可经桡动脉入路成功置入,技术成功率高、入路部位并发症低、转股动脉率低。
研究设计与样本
- 高容量双中心回顾性分析,收集2018年6月至2020年6月各机构数据库中所有经桡动脉入路行血流导向治疗的患者。
- 共74例患者(64例女性),平均年龄57.5岁,共86个动脉瘤。
- 置入装置包括Pipeline Embolization Device(Flex)(PED,n=65)、Surpass Streamline Flow Diverter(n=8)和Flow-Redirection Endoluminal Device(FRED,n=1)。
关键影像表现/征象
- 大多数动脉瘤位于前循环(93%),其中67.4%位于颅内ICA。
- 平均动脉瘤大小为5.5 mm。
诊断标准与关键数值
- 经桡动脉入路成功率为95.9%(71/74),3例(4.1%)因血管迂曲、导管支撑不足(2例)及迷走右锁骨下动脉无法到达目标血管(1例)需转股动脉。
- 未发生入路部位并发症;无症状桡动脉闭塞1例(3.7%)。
临床应用与阅片要点
- 经桡动脉(远端桡动脉/解剖鼻烟壶及桡动脉)入路可用于置入全部3种FDA批准的血流导向装置。
- 血管迂曲、导管支撑不足及迷走右锁骨下动脉是转股动脉的解剖原因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Transradial access for neurointerventional procedures has been proved a safer and more comfortable alternative to femoral artery access. We present our experience with transradial (distal radial/anatomic snuffbox and radial artery) access for treatment of intracranial aneurysms using all 3 FDA-approved flow diverters.
MATERIALS AND METHODS: This was a high-volume, dual-center, retrospective analysis of each institution's data base between June 2018 and June 2020 and a collection of all patients treated with flow diversion via transradial access. Patient demographic information and procedural and radiographic data were obtained.
RESULTS: Seventy-four patients were identified (64 female patients) with a mean age of 57.5 years with a total of 86 aneurysms. Most aneurysms were located in the anterior circulation (93%) and within the intracranial ICA (67.4%). The mean aneurysm size was 5.5 mm. Flow diverters placed included the Pipeline Embolization Device (Flex) (PED, n = 65), the Surpass Streamline Flow Diverter (n = 8), and the Flow-Redirection Endoluminal Device (FRED, n = 1). Transradial access was successful in all cases, but femoral crossover was required in 3 cases (4.1%) due to tortuous anatomy and inadequate support of the catheters in 2 cases and an inability to navigate to the target vessel in a patient with an aberrant right subclavian artery. All 71 other interventions were successfully performed via the transradial approach (95.9%). No access site complications were encountered. Asymptomatic radial artery occlusion was encountered in 1 case (3.7%).
CONCLUSIONS: Flow diverters can be successfully placed via the transradial approach with high technical success, low access site complications, and a low femoral crossover rate.
引用
- Kühn AL, Satti SR, Eden T, et al. Anatomic Snuffbox (Distal Radial Artery) and Radial Artery Access for Treatment of Intracranial Aneurysms with FDA-Approved Flow Diverters. AJNR Am J Neuroradiol. 2021. PMID: 33446501. doi:10.3174/ajnr.A6953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。